NCT05459402View on ClinicalTrials.gov

Divided or Single Exposure (DOSE) Study

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

February 21, 2023

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2028

Conditions
Opioid Use DisorderChronic PainMethadone
Interventions
DRUG

Methadone (100% dose)

Methadone for the treatment of opioid use disorder

DRUG

Methadone (50% dose)

Methadone for the treatment of opioid use disorder

Trial Locations (1)

21224

RECRUITING

Addiction Treatment Services (ATS), Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Maryland, Baltimore

OTHER